Premium
Changes in serum potassium levels occurring in patients treated with triamterene and a triamterene‐hydrochlorothiazide combination
Author(s) -
Hansen Karl B.,
Bender A. Douglas
Publication year - 1967
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1002/cpt196783392
Subject(s) - triamterene , hydrochlorothiazide , hypokalemia , liter , medicine , potassium , hyperkalemia , diuretic , pharmacology , urology , endocrinology , chemistry , blood pressure , organic chemistry
This report summarizes the changes in serum potassium levels in 583 patients treated with triamterene alone, 484 treated with a combination of triamterene and hydrochlorothiazide, and 82 treated with hydrochlorothiazide. The incidence of hypokalemia <3.5 mEq. per liter) in patients treated with a combination of triamterene and hydrochlorothiazide was 6 per cent. Hyperkalemia (>5.4 mEq. per liter) developed in 7.5 per cent of subfects to whom the combination was given, in 12 to 19 per cent of subfects treated with triamterene, and in 4 per cent of patients, especially the severely ill, treated with hydrochlorothiazide.